Navin Fluorine International Limited has informed the Exchange about Transcript
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Navin Fluorine reported a strong Q1 FY26 with revenue up 39% YoY at INR 725 crores, operating EBITDA more than doubling to INR 207 crores, and net profit up 129% at INR 117 crores. EBITDA margins expanded 935 bps to 28.5%, well above the company's earlier 25% guidance. The company recently completed a INR 750 crore QIP at INR 4,680 per share to institutional investors, and the CFO expanded the capex bandwidth to INR 700-1,000 crores from the earlier INR 500-600 crores. The R32 refrigerant plant is running at optimal capacity since March 2025 commercialization, and the firm is in talks with global partners to claim its full quota entitlement. The AHF project is on track for end of Q2 FY26, while a new partnership with Chemours for Opteon immersion cooling fluid and continued work with Buss ChemTech on electronic-grade HF mark progress in the advanced materials space. In CDMO, cGMP4 Phase 1 is on track for Q3 FY26 commercialization, and management reaffirmed the $100 million FY27 target.
The sharp margin beat, expanded capex framework, and strong order book visibility across all three verticals reinforce the growth narrative. Investors should view this as a positive signal for sustained earnings momentum, though stock reaction may be muted as many positives (R32 pricing, margin upside) were already anticipated by the Street.